Quantifying CDK inhibitor selectivity in live cells

Concerted multidisciplinary efforts have led to the development of Cyclin-Dependent Kinase inhibitors (CDKi’s) as small molecule drugs and chemical probes of intracellular CDK function. However, conflicting data has been reported on the inhibitory potency of CDKi’s and a systematic characterization...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, Carrow I., Vasta, James D., Corona, Cesear R., Wilkinson, Jennifer, Zimprich, Chad A., Ingold, Morgan R., Pickett, Julie E., Drewry, David H., Pugh, Kathryn M., Schwinn, Marie K., Hwang, Byounghoon (Brian), Zegzouti, Hicham, Huber, Kilian V. M., Cong, Mei, Meisenheimer, Poncho L., Willson, Timothy M., Robers, Matthew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265341/
https://www.ncbi.nlm.nih.gov/pubmed/32488087
http://dx.doi.org/10.1038/s41467-020-16559-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265341/
https://www.ncbi.nlm.nih.gov/pubmed/32488087
http://dx.doi.org/10.1038/s41467-020-16559-0

Ejemplares similares